Cardamonin Alleviates Pressure Overload-induced Cardiac Remodeling and Dysfunction Through Inhibition of Oxidative...

Area of Science:

• Cardiovascular Research
• Oxidative Stress Biology
• Pharmacology

Background:

• Pressure overload leads to cardiac remodeling and heart failure, primarily driven by oxidative stress.
• Chalcones, like cardamonin, are being investigated for potential therapeutic benefits in cardiovascular diseases.

Purpose of the Study:

• To investigate if cardamonin can mitigate maladaptive cardiac changes and dysfunction induced by pressure overload.
• To elucidate the antioxidant mechanisms underlying cardamonin's protective effects on the heart.

Main Methods:

• In vivo studies using transverse aortic constriction to induce cardiac remodeling in animal models.
• In vitro experiments utilizing H9C2 cells treated with angiotensin II, hydrogen peroxide, or Nox4 overexpression.
• Assessment of oxidative stress markers (superoxide dismutase, L-glutathione, malonaldehyde) and apoptosis-related proteins (Bax, Bcl-2, caspase-3, etc.).

Main Results:

• Cardamonin treatment attenuated cardiac remodeling and dysfunction in vivo.
• Cardamonin significantly reduced oxidative stress and apoptosis in H9C2 cells exposed to various stressors.
• Cardamonin modulated the expression of key apoptosis-related proteins, decreasing pro-apoptotic factors and increasing anti-apoptotic factors.

Conclusions:

• Cardamonin exhibits significant cardioprotective effects against pressure overload-induced heart failure.
• The antioxidant and anti-apoptotic properties of cardamonin are key mechanisms for its therapeutic potential.
• Cardamonin presents a promising therapeutic candidate for managing heart failure associated with oxidative stress.